RARE Market Cap & Key Metrics
Ultragenyx Pharmaceutical Inc.
$14.90
-$0.02(-0.13%)
33
Overall
40
Value
10
Tech
50
Quality
Market Cap
$1.47B
Volume
2.96M
52W Range
$12.73 - $39.89
Target Price
$26.20
RARE market cap is $1.47B. This page lists Ultragenyx Pharmaceutical Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
RARE Key Metrics
- Market cap
- $1.47B
- EPS estimate, current year
- $-3.95
- EPS growth, 3-year
- +16.79%
- Value score
- 40
- Quality score
- 50
- Technical score
- 10
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $673.00M | $560.00M | $434.25M | $363.33M | $351.41M |
| EBITDA | -$536.00M | -$531.00M | -$582.46M | -$640.49M | -$410.32M |
| EPS | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RARE | $14.90 | -0.1% | 2.96M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ultragenyx Pharmaceutical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW